Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical has issued 14,067,797 fully paid ordinary shares, in line with prior announcements, and confirmed that the shares were issued without the need for a disclosure document under the Corporations Act. The company stated it remains compliant with its continuous disclosure and financial reporting obligations and that there is no undisclosed information of the kind that would be required to be released, providing assurance to investors about regulatory compliance around the new share issuance.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$5.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited is a global medical technology company focused on revolutionising respiratory care through advanced imaging and artificial intelligence. Its patented XV Technology converts standard scans into detailed functional lung insights, delivered via a SaaS model, with an expanding portfolio including FDA-cleared XV Lung Ventilation Analysis Software, CT LVAS and the CT:VQ cardiothoracic imaging solution.
Average Trading Volume: 7,737,993
Technical Sentiment Signal: Buy
Current Market Cap: A$3.19B
See more insights into 4DX stock on TipRanks’ Stock Analysis page.